Jinhe Biotechnology CO., LTD. (SHE:002688)

China flag China · Delayed Price · Currency is CNY
6.34
+0.05 (0.79%)
Feb 4, 2026, 3:04 PM CST
45.41%
Market Cap4.73B +46.5%
Revenue (ttm)2.75B +21.6%
Net Income125.51M +29.2%
EPS0.16 +30.9%
Shares Out752.11M
PE Ratio38.53
Forward PE26.21
Dividend0.10 (1.59%)
Ex-Dividend DateJun 6, 2025
Volume11,265,310
Average Volume25,564,283
Open6.68
Previous Close6.29
Day's Range6.25 - 6.68
52-Week Range4.27 - 8.69
Beta0.46
RSI49.36
Earnings DateApr 29, 2026

About SHE:002688

Jinhe Biotechnology CO., LTD. produces and sells veterinary medicines in China and internationally. It offers chlortetracycline premixes; veterinary drug and powder series; disinfectants; and sprinklers. It also engages in the production and sales of feed and raw materials. The company was founded in 1990 and is headquartered in Hohhot, China. [Read more]

Sector Healthcare
Founded 1990
Employees 2,476
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002688
Full Company Profile

Financial Performance

In 2024, SHE:002688's revenue was 2.37 billion, an increase of 9.04% compared to the previous year's 2.17 billion. Earnings were 100.20 million, an increase of 15.90%.

Financial Statements